gimli

GKSL stock AI analysis

GKSL Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

GUJARAT KIDNEY N SUP SP L is a small-cap stock in Healthcare. This Gimli page shows the latest available GKSL price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive GKSL stock page

Price

₹129.86

1W return

-2.17%

1M return

+1.12%

3M return

+15.12%

6M return

+28.61%

1Y return

n/a

Market cap

₹1,023.86 cr

54.87

4.02

ROE

+12.67%

ROCE

+13.36%

RSI

49.69

Turnover

₹3.84 cr

Why it can matter in screens

Momentum: GKSL is below 50DMA, below 200DMA; RSI is 49.69.
Returns: 1D +2.23%, 1W -2.17%, 1M +1.12%, 3M +15.12%, 1Y n/a.
Trend levels: 52W high ₹143.33, 52W low ₹99.36, off high -9.40%.
Liquidity: latest turnover is ₹3.84 cr; volume vs 20D is +0.95%.
Valuation/profitability: PE 54.87, PB 4.02, ROE +12.67%, ROCE +13.36%.
Growth: 3Y sales CAGR -1.49%, 3Y profit CAGR +32.65%.

Quick Answers

What is the latest GKSL stock price?

The latest stored price for GKSL is Rs 129.86 as of 2026-07-21.

Is GKSL above its 50DMA and 200DMA?

GKSL is below 50DMA, below 200DMA. The latest 50DMA is 132.91 and the latest 200DMA is n/a.

What are GKSL PE, ROE and ROCE?

GKSL has PE 54.87, ROE +12.67%, and ROCE +13.36% in Gimli's latest available snapshot.

How has GKSL performed recently?

GKSL has returned +1.12% over 1 month, +15.12% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	30.58 cr	7.01 cr	5.04 cr	0.81
2025-12-31	23.25 cr	6.96 cr	2.94 cr	0.52
2025-09-30	13.02 cr	5.21 cr	2.88 cr	0.47
2025-06-30	31.09 cr	13.66 cr	7.80 cr	0.99
2025-03-31	9.78 cr	2.67 cr	1.28 cr	0.16
2024-12-31	11.79 cr	4.65 cr	2.50 cr	0.32

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	82.01 cr	27.81 cr	15.50 cr	2.49
2025-03-31	40.24 cr	16.70 cr	9.41 cr	1.19
2024-03-31	103.44 cr	22.03 cr	9.68 cr	1.23
2023-03-31	85.79 cr	17.93 cr	6.64 cr	0.84

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	297.64 cr	13.28 cr	29.11 cr	254.74 cr
2025-03-31	91.29 cr	4.58 cr	22.77 cr	39.83 cr
2024-03-31	65.40 cr	3.90 cr	27.34 cr	22.85 cr
2023-03-31	63.86 cr	1.90 cr	23.20 cr	22.30 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	-3.86 cr	-157.28 cr	n/a
2025-03-31	13.61 cr	-4.64 cr	n/a
2024-03-31	1.21 cr	1.21 cr	n/a
2023-03-31	0.00 cr	0.00 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-03-31	+71.45%	+4.88%	+0.56%	+0.00%	+23.10%	+0.00%
2025-12-31	+71.45%	+10.47%	+1.67%	+0.00%	+16.40%	+0.00%
2025-12-29	+71.45%	+13.09%	+7.84%	+0.00%	+7.62%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	470,725.53 cr	40.938102	+14.71%	+15.93%
DIVISLAB	DIVI S LABORATORIES LTD	194,588.48 cr	75.774332	+16.19%	+9.60%
TORNTPHARM	TORRENT PHARMACEUTICALS L	170,600.17 cr	78.872017	+17.18%	+43.04%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	128,349.41 cr	65.537894	+21.03%	+23.05%
CIPLA	CIPLA LTD	115,717.42 cr	29.815932	+11.79%	-2.81%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	115,022.61 cr	22.938459	+17.93%	+17.85%
LUPIN	LUPIN LIMITED	114,980.65 cr	21.532280	+26.83%	+30.91%
MAXHEALTH	MAX HEALTHCARE INS LTD	107,095.75 cr	74.247785	+14.33%	-9.67%

Try these prompts

Analyze GUJARAT KIDNEY N SUP SP L with valuation, momentum and industry peers
Compare GKSL with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-07-21. Not investment advice.